Resonance Specialities Ltd
₹ 104
-1.38%
27 Jan
- close price
About
Resonance Specialities Ltd is engaged in the business of manufacturing of chemicals like pyridine, picoline, cyanopyridine and their derivatives.[1]
Key Points
- Market Cap ₹ 120 Cr.
- Current Price ₹ 104
- High / Low ₹ 215 / 102
- Stock P/E 14.2
- Book Value ₹ 46.4
- Dividend Yield 0.96 %
- ROCE 34.9 %
- ROE 26.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 63.6% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.7%
Cons
- Earnings include an other income of Rs.3.49 Cr.
- Promoter holding has decreased over last 3 years: -10.5%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
28.62 | 35.62 | 39.52 | 45.30 | 37.84 | 38.63 | 33.91 | 35.71 | 41.40 | 56.14 | 70.29 | 73.93 | 65.10 | |
25.85 | 34.68 | 37.36 | 42.19 | 36.59 | 35.62 | 31.89 | 35.06 | 36.51 | 48.39 | 56.04 | 58.72 | 55.88 | |
Operating Profit | 2.77 | 0.94 | 2.16 | 3.11 | 1.25 | 3.01 | 2.02 | 0.65 | 4.89 | 7.75 | 14.25 | 15.21 | 9.22 |
OPM % | 9.68% | 2.64% | 5.47% | 6.87% | 3.30% | 7.79% | 5.96% | 1.82% | 11.81% | 13.80% | 20.27% | 20.57% | 14.16% |
0.13 | 0.14 | 0.38 | -0.38 | 1.86 | 0.26 | 0.82 | 1.08 | 1.31 | 0.44 | 1.59 | 2.90 | 3.49 | |
Interest | 0.59 | 0.64 | 0.76 | 0.59 | 0.58 | 0.52 | 0.39 | 0.55 | 0.54 | 0.35 | 0.29 | 0.07 | 0.06 |
Depreciation | 1.21 | 1.08 | 1.15 | 1.10 | 1.16 | 1.12 | 1.06 | 1.15 | 0.91 | 0.92 | 0.98 | 1.75 | 1.53 |
Profit before tax | 1.10 | -0.64 | 0.63 | 1.04 | 1.37 | 1.63 | 1.39 | 0.03 | 4.75 | 6.92 | 14.57 | 16.29 | 11.12 |
Tax % | 47.27% | 17.19% | 25.40% | 0.96% | 7.30% | 27.61% | 25.90% | 2,700.00% | 32.63% | 20.38% | 27.73% | 24.06% | |
Net Profit | 0.58 | -0.53 | 0.46 | 1.03 | 1.28 | 1.19 | 1.03 | -0.77 | 3.20 | 5.51 | 10.52 | 12.36 | 8.40 |
EPS in Rs | 0.50 | -0.46 | 0.40 | 0.89 | 1.11 | 1.03 | 0.89 | -0.67 | 2.77 | 4.77 | 9.11 | 10.71 | 7.28 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 56.02% | 45.08% | 0.00% | 0.00% | 0.00% | 0.00% | 20.94% | 10.97% | 9.34% |
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 17% |
3 Years: | 21% |
TTM: | -16% |
Compounded Profit Growth | |
---|---|
10 Years: | 46% |
5 Years: | 64% |
3 Years: | 56% |
TTM: | -33% |
Stock Price CAGR | |
---|---|
10 Years: | 22% |
5 Years: | 22% |
3 Years: | 38% |
1 Year: | -44% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 20% |
3 Years: | 27% |
Last Year: | 27% |
Balance Sheet
Figures in Rs. Crores
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | |
Reserves | 10.13 | 9.28 | 9.42 | 9.45 | 9.95 | 11.14 | 12.42 | 11.72 | 14.93 | 18.99 | 29.13 | 40.26 | 42.03 |
3.00 | 3.53 | 3.45 | 3.38 | 3.12 | 1.92 | 4.07 | 3.40 | 0.00 | 0.00 | 0.72 | 0.09 | 0.08 | |
10.52 | 7.93 | 8.74 | 9.77 | 9.95 | 7.76 | 11.75 | 10.19 | 11.70 | 10.60 | 13.25 | 4.89 | 7.74 | |
Total Liabilities | 35.19 | 32.28 | 33.15 | 34.14 | 34.56 | 32.36 | 39.78 | 36.85 | 38.17 | 41.13 | 54.64 | 56.78 | 61.39 |
18.13 | 17.65 | 16.56 | 15.22 | 14.26 | 13.86 | 15.06 | 14.60 | 14.07 | 14.11 | 15.90 | 13.83 | 14.82 | |
CWIP | 1.02 | 0.40 | 0.03 | 0.03 | 0.03 | 0.13 | 0.20 | 0.60 | 0.83 | 1.84 | 0.04 | 0.44 | 3.09 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.75 | 0.12 | 0.00 |
16.04 | 14.23 | 16.56 | 18.89 | 20.27 | 18.37 | 24.52 | 21.65 | 23.27 | 25.08 | 37.95 | 42.39 | 43.48 | |
Total Assets | 35.19 | 32.28 | 33.15 | 34.14 | 34.56 | 32.36 | 39.78 | 36.85 | 38.17 | 41.13 | 54.64 | 56.78 | 61.39 |
Cash Flows
Figures in Rs. Crores
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2.54 | 0.56 | 0.79 | 1.76 | 1.11 | 3.23 | 0.56 | 2.14 | 5.27 | 1.42 | 4.28 | 13.33 | |
-1.75 | -0.37 | 0.00 | -0.07 | -0.28 | -0.82 | -2.62 | -1.11 | -0.50 | -1.82 | -1.18 | -8.80 | |
-0.82 | -0.14 | -0.84 | -0.60 | -1.52 | -2.41 | 1.76 | -1.01 | -3.65 | 1.15 | 0.31 | -1.86 | |
Net Cash Flow | -0.03 | 0.05 | -0.05 | 1.09 | -0.69 | 0.01 | -0.30 | 0.02 | 1.11 | 0.76 | 3.42 | 2.66 |
Ratios
Figures in Rs. Crores
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 88.64 | 65.68 | 70.75 | 76.63 | 99.16 | 66.05 | 79.76 | 67.97 | 66.74 | 39.92 | 48.92 | 40.48 |
Inventory Days | 192.36 | 88.72 | 105.52 | 81.52 | 133.71 | 159.21 | 397.20 | 211.58 | 180.17 | 232.12 | 236.12 | 175.79 |
Days Payable | 171.29 | 62.78 | 69.49 | 68.68 | 116.18 | 108.07 | 262.26 | 127.21 | 138.98 | 114.32 | 120.62 | 17.35 |
Cash Conversion Cycle | 109.71 | 91.62 | 106.78 | 89.46 | 116.69 | 117.19 | 214.70 | 152.35 | 107.93 | 157.71 | 164.41 | 198.92 |
Working Capital Days | 99.73 | 84.95 | 94.02 | 83.15 | 100.80 | 91.94 | 128.09 | 114.27 | 93.19 | 81.92 | 102.61 | 146.63 |
ROCE % | 7.50% | 0.98% | 5.70% | 7.30% | 3.96% | 8.74% | 6.84% | 2.23% | 20.21% | 30.63% | 41.32% | 34.91% |
Documents
Announcements
- Board Meeting Intimation for Un-Audited Financial Results For The 3Rd Quarter And Nine Months Ended December 31, 2022 24 Jan
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
17 Jan - Revised Submission of Certificate under Regulation 74(5) of the SEBI [Depositories and Participants) Regulations, 2018 for the Quarter ended December 31, 2022 due to incorrect …
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
17 Jan - Submission of Certificate under Regulation 74(5) of the SEBI [Depositories and Participants) Regulations, 2018 for the Quarter ended December 31, 2022
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 16 Jan
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 16 Jan
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Portfolio
The company manufactures and markets specialty chemicals based on pyridine chemistry such as Lutidine, cyano Pyridines, picoline, collidines, nutritional products, feed supplements, APIs, vitamins, etc.[1]